Published 20 days ago • loading... • Updated 19 days ago

The Future of Cancer Care: A $326 Billion Revolution on the Horizon

Summary by elblog.pl

The Cancer Therapeutics Market is projected to grow from USD 162.58 billion in 2024 to USD 326.35 billion by 2032, driven by a robust CAGR of 9.1% from 2025 to 2032. North America, particularly the United States, leads in innovation, while global regions including Europe, Asia-Pacific, and emerging markets contribute to market expansion. Technological advancements combined with economic and non-economic factors support diverse cancer treatments,…

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All

Left

Center

Right

Daily Investor Hub

Global Antibody Drug Conjugates Market Witnessing Strong Growth with a 9% CAGR by 2030 - Daily Investor Hub

The antibody drug conjugates (ADCs) market is projected to grow at a CAGR of ~9% over the forecast period. Major factors driving growth include the growing prevalence of cancer, increasing demand for targeted cancer therapies, advancement in ADC technology, growing investment in R&D for introducing new antibody-drug conjugates, and increasing approvals by regulatory bodies such as the FDA and EMA for ADCs. However, the market encounters certain …

19 days ago

Read Full Article